檢索結果 - P L Amlot
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy 由 P L Amlot, MJ Stone, David Cunningham, Joseph W. Fay, Joseph T. Newman, Robert H. Collins, Richard May, Mairin McCarthy, Jane Richardson, Victor Gheţie
出版 1993Artigo -
12
Incubation Phase of Acute Hepatitis B in Man: Dynamic of Cellular Immune Mechanisms 由 George Webster, Stephanie Reignat, Mala K. Maini, Simon Whalley, Graham S. Ogg, Abigail Selzer King, David Brown, P L Amlot, Roger Williams, Diego Vergani, Geoffrey Dusheiko, Antonio Bertoletti
出版 2000Artigo -
13
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease 由 F. Gordon, Clement Lai, Mark I. Hamilton, M C Allison, Emmanuel D. Srivastava, Marilyn G. Fouweather, Stephen Donoghue, Carol Greenlees, Javaid Subhani, P L Amlot, Roy E. Pounder
出版 2001Artigo -
14
A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation 由 Lesley Rees, E. Jane Tizard, Andrew Morgan, W. D. Cubitt, S. Finerty, T Oyewole-Eletu, Karen Owen, Collin Royed, Servi J.C. Stevens, Rukshana Shroff, Manjit Tanday, A.D. Wilson, Jaap M. Middeldorp, P L Amlot, Neil Steven
出版 2009Artigo -
15
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial 由 Tanzina Haque, Gwen Wilkie, Marie M. Jones, Craig Higgins, G. E. D. Urquhart, Phoebe J Wingate, David Burns, Karen A. McAulay, Marc Turner, Christopher Bellamy, P L Amlot, Déirdre Kelly, Alastair MacGilchrist, Maher K. Gandhi, Anthony J. Swerdlow, Dorothy H. Crawford
出版 2007Artigo
相關主題
Immunology
Medicine
Biology
Antibody
Biochemistry
Internal medicine
Immune system
Antigen
CD8
Gastroenterology
In vitro
Monoclonal antibody
Chemistry
Cytotoxic T cell
Molecular biology
Transplantation
CTL*
Gene
Lymphoma
T cell
Virology
Virus
Adverse effect
Alternative medicine
B cell
Biotechnology
CD3
Clinical endpoint
Clinical trial
Computer science